Modulation of LMP1 protein expression by EBV-encoded microRNAs

Epstein–Barr virus (EBV) was the first human virus found to encode microRNAs (miRNAs), but the function of these miRNAs has been obscure. Nasopharyngeal carcinoma (NPC) is associated with EBV infection, and the EBV-encoded LMP1 is believed to be a key factor in NPC development. However, detection of LMP1 protein in NPC is variable. Here, we report that EBV-encoded BART miRNAs target the 3′ UTR of the LMP1 gene and negatively regulate LMP1 protein expression. These miRNAs also modulate LMP1-induced NF-κB signaling and alleviate the cisplatin sensitivity of LMP1-expressing NPC cells. Consistent with a previous study on the NPC C666-1 cell line and C15 xenograft, we found abundant expression of BART miRNAs in NPC tissues. Furthermore, DNA sequencing revealed that the 3′ UTR of LMP1 is highly conserved in NPC-derived EBV isolates. The data provide insight into the discrepancy between LMP1 transcript and protein detection in NPC and highlight the role of the EBV miRNAs in regulating LMP1 downstream signaling to promote cancer development.

[1]  E. Hui,et al.  Analysis of Epstein-Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays. , 2006, The Journal of general virology.

[2]  D. Walling,et al.  Oncogenic Activity of Epstein-Barr Virus Latent Membrane Protein 1 (LMP-1) Is Down-Regulated by Lytic LMP-1 , 2006, Journal of Virology.

[3]  G. Bornkamm,et al.  Autoactivation of the Epstein-Barr Virus Oncogenic Protein LMP1 during Type II Latency through Opposite Roles of the NF-κB and JNK Signaling Pathways , 2006, Journal of Virology.

[4]  B. Cullen.  Viruses and microRNAs , 2006, Nature Genetics.

[5]  Adam Grundhoff,et al.  A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. , 2006, RNA.

[6]  Alexandra Schäfer,et al.  Epstein–Barr Virus MicroRNAs Are Evolutionarily Conserved and Differentially Expressed , 2006, PLoS pathogens.

[7]  Stijn van Dongen,et al.  miRBase: microRNA sequences, targets and gene nomenclature , 2005, Nucleic Acids Res..

[8]  D. Stevenson,et al.  Epstein-Barr virus latent membrane protein 1 (CAO) up-regulates VEGF and TGF alpha concomitant with hyperlasia, with subsequent up-regulation of p16 and MMP9. , 2005, Cancer research.

[9]  L. Young,et al.  Epstein–Barr virus: 40 years on , 2004, Nature Reviews Cancer.

[10]  Anton J. Enright,et al.  Identification of Virus-Encoded MicroRNAs , 2004, Science.

[11]  Yu-Ting Chang,et al.  Epstein–Barr virus latent membrane protein 1 induces micronucleus formation, represses DNA repair and enhances sensitivity to DNA-damaging agents in human epithelial cells , 2004, Oncogene.

[12]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[13]  N. Raab-Traub,et al.  Potential Selection of LMP1 Variants in Nasopharyngeal Carcinoma , 2004, Journal of Virology.

[14]  E. Kieff,et al.  Epstein–Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKKα-dependent noncanonical NF-κB activation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[15]  L. Young,et al.  Epstein–Barr virus and oncogenesis: from latent genes to tumours , 2003, Oncogene.

[16]  Y. Wong,et al.  Alterations of Biologic Properties and Gene Expression in Nasopharyngeal Epithelial Cells by the Epstein-Barr Virus–Encoded Latent Membrane Protein 1 , 2003, Laboratory Investigation.

[17]  L. Hutt-Fletcher,et al.  A Positive Autoregulatory Loop of LMP1 Expression and STAT Activation in Epithelial Cells Latently Infected with Epstein-Barr Virus , 2003, Journal of Virology.

[18]  J. Minárovits,et al.  Host cell-dependent expression of latent Epstein-Barr virus genomes: regulation by DNA methylation. , 2003, Advances in cancer research.

[19]  N. Raab-Traub.  Epstein-Barr virus in the pathogenesis of NPC. , 2002, Seminars in cancer biology.

[20]  S. Tsao,et al.  The significance of LMP1 expression in nasopharyngeal carcinoma. , 2002, Seminars in cancer biology.

[21]  S. Tsao,et al.  Latent membrane protein‐1 of Epstein‐Barr virus inhibits cell growth and induces sensitivity to cisplatin in nasopharyngeal carcinoma cells , 2002, Journal of medical virology.

[22]  P. Smith.  Epstein-Barr virus complementary strand transcripts (CSTs/BARTs) and cancer. , 2001, Seminars in cancer biology.

[23]  M. Kawanishi.  The Epstein-Barr virus latent membrane protein 1 (LMP1) enhances TNF alpha-induced apoptosis of intestine 407 epithelial cells: the role of LMP1 C-terminal activation regions 1 and 2. , 2000, Virology.

[24]  Philip Smith,et al.  Structure and Coding Content of CST (BART) Family RNAs of Epstein-Barr Virus , 2000, Journal of Virology.

[25]  B. Rayet,et al.  Aberrant rel/nfkb genes and activity in human cancer , 1999, Oncogene.

[26]  E. Kieff,et al.  The Epstein–Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-κB , 1997 .

[27]  E. Kieff,et al.  CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr Virus-encoded LMP1: involvement of TRAF3 as a common mediator. , 1996, Oncogene.

[28]  J. Chen,et al.  Induction of apoptosis in epithelial cells by Epstein-Barr virus latent membrane protein 1. , 1996, The Journal of general virology.

[29]  L. Young,et al.  Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells , 1993, The Journal of experimental medicine.

[30]  J. Sham,et al.  Transcription of BamHI-A region of the EBV genome in NPC tissues and B cells. , 1992, Virology.

[31]  Philip Smith,et al.  Expression of a family of complementary-strand transcripts in Epstein-Barr virus-infected cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Abdel-hamid,et al.  Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: evidence for a viral protein expressed in vivo , 1991, Journal of virology.

[33]  I. Ernberg,et al.  Variable expression of latent membrane protein in nasopharyngeal carcinoma can be related to methylation status of the Epstein-Barr virus BNLF-1 5'-flanking region , 1991, Journal of virology.